Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Debt-to-Equity : 0.19 (As of Sep. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Fisher & Paykel Healthcare Debt-to-Equity?

Fisher & Paykel Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $14 Mil. Fisher & Paykel Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $178 Mil. Fisher & Paykel Healthcare's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $1,039 Mil. Fisher & Paykel Healthcare's debt to equity for the quarter that ended in Sep. 2023 was 0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fisher & Paykel Healthcare's Debt-to-Equity or its related term are showing as below:

FSPKF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06 Med: 0.11 Max: 0.27
Current: 0.19

During the past 13 years, the highest Debt-to-Equity Ratio of Fisher & Paykel Healthcare was 0.27. The lowest was 0.06. And the median was 0.11.

FSPKF's Debt-to-Equity is ranked better than
52.91% of 705 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FSPKF: 0.19

Fisher & Paykel Healthcare Debt-to-Equity Historical Data

The historical data trend for Fisher & Paykel Healthcare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Debt-to-Equity Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.10

0.14

0.08

0.06

0.08

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															0.07	0.06	0.08	0.08	0.19

Competitive Comparison of Fisher & Paykel Healthcare's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Debt-to-Equity falls into.

Fisher & Paykel Healthcare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fisher & Paykel Healthcare's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.222	+	77.281)	/	1088.392
	=	0.08

Fisher & Paykel Healthcare's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14.116	+	177.699)	/	1039.027
	=	0.18

Fisher & Paykel Healthcare (OTCPK:FSPKF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fisher & Paykel Healthcare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (OTCPK:FSPKF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

FPH:New Zealand FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.

Fisher & Paykel Healthcare (Fisher & Paykel Healthcare) Headlines

From GuruFocus

Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis

By GuruFocus Research • 12-04-2023